Eliem Therapeutics Inc (ELYM)
10.16
+1.76
(+21.04%)
USD |
NASDAQ |
May 03, 16:00
10.14
-0.02
(-0.15%)
After-Hours: 20:00
Eliem Therapeutics Total Liabilities (Quarterly): 2.87M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.87M |
| September 30, 2023 | 2.993M |
| June 30, 2023 | 3.773M |
| March 31, 2023 | 5.225M |
| December 31, 2022 | 6.277M |
| September 30, 2022 | 6.499M |
| June 30, 2022 | 7.87M |
| Date | Value |
|---|---|
| March 31, 2022 | 7.277M |
| December 31, 2021 | 6.038M |
| September 30, 2021 | 5.59M |
| June 30, 2021 | 5.713M |
| March 31, 2021 | 4.07M |
| December 31, 2020 | 3.063M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.87M
Minimum
Dec 2023
7.87M
Maximum
Jun 2022
5.174M
Average
5.59M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Alpine Immune Sciences Inc | 51.91M |
| Candel Therapeutics Inc | 28.46M |
| Cyclacel Pharmaceuticals Inc | 8.198M |
| Lipocine Inc | 2.632M |
| GlycoMimetics Inc | 6.902M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 110.47M |
| Shareholders Equity (Quarterly) | 107.60M |